We are live on ! Find out more
SFM

Sphera Funds Management Portfolio holdings

AUM $767M
1-Year Est. Return 119.71%
This Fund
S&P 500
This Quarter Est. Return
-2.89%
1 Year Est. Return
+119.71%
3 Year Est. Return
+244.81%
5 Year Est. Return
+382.5%
10 Year Est. Return
+2,655.81%
AUM
$935M
AUM Growth
+$227M
Cap. Flow
-$29.6M
Cap. Flow %
-3.17%
Top 10 Hldgs %
70.78%
Holding
86
New
20
Increased
18
Reduced
12
Closed
29

Top Buys

Rank Stock Value
1
XBI icon
State Street SPDR S&P Biotech ETF
XBI
+$32.9M
2
LLY icon
Eli Lilly
LLY
+$18.6M
3
FIVN icon
FIVE9
FIVN
+$11.3M
4
NICE icon
Nice
NICE
+$11.2M
5
META icon
Meta Platforms (Facebook)
META
+$9.65M

Top Sells

Rank Stock Value
1
PFE icon
Pfizer
PFE
+$26.7M
2
BMRN icon
BioMarin Pharmaceuticals
BMRN
+$16.3M
3
KYMR icon
Kymera Therapeutics
KYMR
+$15.6M
4
ZIM icon
ZIM Integrated Shipping Services
ZIM
+$10.8M
5
GNRC icon
Generac Holdings
GNRC
+$9.81M

Sector Composition

Rank Sector Weight
1 Miscellaneous 47.92%
2 Healthcare 47.59%
3 Technology 3.05%
4 Communication Services 0.86%
5 Financials 0.27%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
S icon
76
SentinelOne
S
$8.07B
– –
-65,000
Closed -$2.52M
SWTX
77
CALL
DELISTED
SpringWorks Therapeutics
SWTX
– –
-125,000
Closed -$7.05M
TEVA icon
78
PUT
Teva Pharmaceutical Industries Limited
TEVA
$45.7B
– –
-210,000
Closed -$1.97M
VRNA
79
DELISTED
Verona Pharma
VRNA
– –
-666,339
Closed -$3.33M
ZIM icon
80
ZIM Integrated Shipping Services
ZIM
$3.66B
– –
-148,000
Closed -$10.8M
LIAN
81
DELISTED
LianBio American Depositary Shares
LIAN
– –
-275,007
Closed -$1.02M
AYLA
82
DELISTED
Ayala Pharmaceuticals, Inc. Common Stock
AYLA
– –
-250,000
Closed -$995K
IS
83
DELISTED
ironSource Ltd.
IS
– –
-620,000
Closed -$2.98M
1 2 3
4

Similar funds

ISWM
Independent Solutions Wealth Management Williamsville, New York $766M AUM 31.53% 1-Year Est. Return
ACP
Albar Capital Partners London, United Kingdom $767M AUM 61.96% 1-Year Est. Return
NIM
Nexus Investment Management Toronto, Ontario, Canada $767M AUM 30.97% 1-Year Est. Return
ACM
Arvin Capital Management Austin, Texas $766M AUM 36.51% 1-Year Est. Return
CBT
Crews Bank & Trust Wauchula, Florida $766M AUM 19.5% 1-Year Est. Return
SPIA
Strategic Point Investment Advisors Providence, Rhode Island $767M AUM 17.58% 1-Year Est. Return
CNB
Camden National Bank Camden, Maine $767M AUM 14.32% 1-Year Est. Return
HI
Hendershot Investments Centreville, Virginia $766M AUM 10.81% 1-Year Est. Return

Sphera Funds Management's Q2 2022 Portfolio in Review

As of Q2 2022, Sphera Funds Management held 86 positions worth $935M, up 32% from $708M the previous quarter. Its ten largest holdings account for 71% of the portfolio.

Sphera Funds Management withdrew a net $29.6M in Q2 2022, closing 29 positions and reducing 12 holdings. Its most notable exit was Pfizer, an estimated $26.7M position sold in full.

By sector, the portfolio is most concentrated in Miscellaneous at 48% of assets, up from 16% a quarter earlier, followed by Healthcare and Technology.

Against the trend, Sphera Funds Management opened a new position in State Street SPDR S&P Biotech ETF worth $32.5M.

  • Sphera Funds Management's largest Q2 2022 buy was State Street SPDR S&P Biotech ETF: 437,748 shares worth $32.5M.
  • Sphera Funds Management added most to Eli Lilly in Q2 2022, an estimated $18.6M increase.
  • Sphera Funds Management's biggest Q2 2022 reduction was Generac Holdings, cutting an estimated $9.81M.
  • Sphera Funds Management fully exited Pfizer in Q2 2022, selling an estimated $26.7M.
  • Sphera Funds Management's ten largest holdings make up 71% of its $935M portfolio in Q2 2022.
  • Sphera Funds Management opened 20 new positions and closed 29 in Q2 2022.
  • Sphera Funds Management's portfolio value rose 32% quarter-over-quarter to $935M.

Based on Sphera Funds Management's 13F filing for Q2 2022, filed 15 Aug 2022.